The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy

Circulating tumor cells (CTCs) have aroused increasing interest not only in mechanistic studies of metastasis, but also for translational applications, such as patient monitoring, treatment choice, and treatment change due to tumor resistance. In this review, we will assess the state of the art abou...

Full description

Bibliographic Details
Main Authors: Kevin Leone, Cristina Poggiana, Rita Zamarchi
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Diagnostics
Subjects:
Online Access:http://www.mdpi.com/2075-4418/8/3/59
id doaj-9f5561fb53404a11a2d6d9bd078a26b8
record_format Article
spelling doaj-9f5561fb53404a11a2d6d9bd078a26b82020-11-24T22:09:46ZengMDPI AGDiagnostics2075-44182018-08-01835910.3390/diagnostics8030059diagnostics8030059The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer ImmunotherapyKevin Leone0Cristina Poggiana1Rita Zamarchi2Veneto Institute of Oncology IOV—IRCCS, Padua, ItalyVeneto Institute of Oncology IOV—IRCCS, Padua, ItalyVeneto Institute of Oncology IOV—IRCCS, Padua, ItalyCirculating tumor cells (CTCs) have aroused increasing interest not only in mechanistic studies of metastasis, but also for translational applications, such as patient monitoring, treatment choice, and treatment change due to tumor resistance. In this review, we will assess the state of the art about the study of the interactions between CTCs and the immune system. We intend to analyze the impact that the cells of the immune system have in limiting or promoting the metastatic capability of CTCs. To this purpose, we will examine studies that correlate CTCs, immune cells, and patient prognosis, and we will also discuss relevant animal models that have contributed to the understanding of the mechanisms of immune-mediated metastasis. We will then consider some studies in which CTCs seem to play a promising role in monitoring cancer patients during immunotherapy regimens. We believe that, from an accurate and profound knowledge of the interactions between CTCs and the immune system, new immunotherapeutic strategies against cancer might emerge in the future.http://www.mdpi.com/2075-4418/8/3/59circulating tumor cellsimmune systemimmunotherapycancer biomarkersliquid biopsymetastasis
collection DOAJ
language English
format Article
sources DOAJ
author Kevin Leone
Cristina Poggiana
Rita Zamarchi
spellingShingle Kevin Leone
Cristina Poggiana
Rita Zamarchi
The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
Diagnostics
circulating tumor cells
immune system
immunotherapy
cancer biomarkers
liquid biopsy
metastasis
author_facet Kevin Leone
Cristina Poggiana
Rita Zamarchi
author_sort Kevin Leone
title The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
title_short The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
title_full The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
title_fullStr The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
title_full_unstemmed The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
title_sort interplay between circulating tumor cells and the immune system: from immune escape to cancer immunotherapy
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2018-08-01
description Circulating tumor cells (CTCs) have aroused increasing interest not only in mechanistic studies of metastasis, but also for translational applications, such as patient monitoring, treatment choice, and treatment change due to tumor resistance. In this review, we will assess the state of the art about the study of the interactions between CTCs and the immune system. We intend to analyze the impact that the cells of the immune system have in limiting or promoting the metastatic capability of CTCs. To this purpose, we will examine studies that correlate CTCs, immune cells, and patient prognosis, and we will also discuss relevant animal models that have contributed to the understanding of the mechanisms of immune-mediated metastasis. We will then consider some studies in which CTCs seem to play a promising role in monitoring cancer patients during immunotherapy regimens. We believe that, from an accurate and profound knowledge of the interactions between CTCs and the immune system, new immunotherapeutic strategies against cancer might emerge in the future.
topic circulating tumor cells
immune system
immunotherapy
cancer biomarkers
liquid biopsy
metastasis
url http://www.mdpi.com/2075-4418/8/3/59
work_keys_str_mv AT kevinleone theinterplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
AT cristinapoggiana theinterplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
AT ritazamarchi theinterplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
AT kevinleone interplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
AT cristinapoggiana interplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
AT ritazamarchi interplaybetweencirculatingtumorcellsandtheimmunesystemfromimmuneescapetocancerimmunotherapy
_version_ 1725810829245284352